Oxybate Accord (Sodium Oxybate)

Sodium Oxybate, the active ingredient in Oxybate Accord, is a central nervous system depressant presented as a oral solution for oral use. It treats cataplexy and excessive daytime sleepiness in patients with narcolepsy. GNH USA supplies Oxybate Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Oxybate Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Oxybate Accord is a sodium‑based medication that works within the narcolepsy pathway of sleep‑wake regulation.

- Narcolepsy with cataplexy: Improves nighttime sleep consolidation and reduces cataplexy episodes. - Narcolepsy without cataplexy : Enhances the quality of day‑time alert ‑ decreases excess sleep of the by the … -  …  ...